These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26581860)

  • 1. Ventral midbrain dopaminergic neurons: From neurogenesis to neurodegeneration.
    Huang EJ
    FEBS Lett; 2015 Dec; 589(24 Pt A):3691-2. PubMed ID: 26581860
    [No Abstract]   [Full Text] [Related]  

  • 2. GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease.
    Kramer ER; Liss B
    FEBS Lett; 2015 Dec; 589(24 Pt A):3760-72. PubMed ID: 26555190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
    Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
    Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing neurogenesis for the possible treatment of Parkinson's disease.
    Lamm O; Ganz J; Melamed E; Offen D
    J Comp Neurol; 2014 Aug; 522(12):2817-30. PubMed ID: 24723264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development.
    Hegarty SV; Sullivan AM; O'Keeffe GW
    Dev Biol; 2013 Jul; 379(2):123-38. PubMed ID: 23603197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of cellular models of dopamine neurons for disease.
    Canavier CC; Evans RC; Oster AM; Pissadaki EK; Drion G; Kuznetsov AS; Gutkin BS
    J Neurophysiol; 2016 Dec; 116(6):2815-2830. PubMed ID: 27582295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization.
    German DC; Manaye K; Smith WK; Woodward DJ; Saper CB
    Ann Neurol; 1989 Oct; 26(4):507-14. PubMed ID: 2817827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired motor coordination in Pitx3 overexpression mice.
    Kim H; Quan X; Seong Y; Kim J
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1211-8. PubMed ID: 24680684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of development of morphofunctional interconnections between CART- and AGRP-ergic neurons with dopaminergic structures in ontogenesis of mammals].
    Romanova IV; Mikhrina AL; Chernysheva MP
    Zh Evol Biokhim Fiziol; 2014; 50(5):392-8. PubMed ID: 25786322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity and development of local inhibitory and excitatory neurons associated with dopaminergic nuclei.
    Morello F; Partanen J
    FEBS Lett; 2015 Dec; 589(24 Pt A):3693-701. PubMed ID: 26453835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of the midbrain dopamine system: Implications for Parkinson disease.
    Hassan A; Benarroch EE
    Neurology; 2015 Nov; 85(20):1795-805. PubMed ID: 26475693
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain.
    Eslamboli A; Romero-Ramos M; Burger C; Bjorklund T; Muzyczka N; Mandel RJ; Baker H; Ridley RM; Kirik D
    Brain; 2007 Mar; 130(Pt 3):799-815. PubMed ID: 17303591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The function and mechanisms of Nurr1 action in midbrain dopaminergic neurons, from development and maintenance to survival.
    Luo Y
    Int Rev Neurobiol; 2012; 102():1-22. PubMed ID: 22748824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
    Luk KC; Rymar VV; van den Munckhof P; Nicolau S; Steriade C; Bifsha P; Drouin J; Sadikot AF
    J Neurochem; 2013 Jun; 125(6):932-43. PubMed ID: 23331067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease.
    Arenas E
    J Mol Cell Biol; 2014 Feb; 6(1):42-53. PubMed ID: 24431302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?
    Le Pen G; Sonnier L; Hartmann A; Bizot JC; Trovero F; Krebs MO; Prochiantz A
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S107-11. PubMed ID: 18585951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse roles for Wnt7a in ventral midbrain neurogenesis and dopaminergic axon morphogenesis.
    Fernando CV; Kele J; Bye CR; Niclis JC; Alsanie W; Blakely BD; Stenman J; Turner BJ; Parish CL
    Stem Cells Dev; 2014 Sep; 23(17):1991-2003. PubMed ID: 24803261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-cadherin regulates the proliferation and differentiation of ventral midbrain dopaminergic progenitors.
    Sakane F; Miyamoto Y
    Dev Neurobiol; 2013 Jul; 73(7):518-29. PubMed ID: 23420609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular regulation of GABAergic neuron differentiation and diversity in the developing midbrain.
    Lahti L; Achim K; Partanen J
    Acta Physiol (Oxf); 2013 Apr; 207(4):616-27. PubMed ID: 23297792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signaling in midbrain dopaminergic neuron specification and neurogenesis.
    Joksimovic M; Awatramani R
    J Mol Cell Biol; 2014 Feb; 6(1):27-33. PubMed ID: 24287202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.